A
Price
$124.76
Change
-$1.18 (-0.94%)
Updated
Sep 24, 11:42 AM (EDT)
Capitalization
35.7B
68 days until earnings call
RGEN
Price
$125.09
Change
+$1.14 (+0.92%)
Updated
Sep 24, 12:26 PM (EDT)
Capitalization
6.97B
41 days until earnings call
Interact to see
Advertisement

A vs RGEN

Header iconA vs RGEN Comparison
Open Charts A vs RGENBanner chart's image
Agilent Technologies
Price$124.76
Change-$1.18 (-0.94%)
Volume$550
Capitalization35.7B
Repligen
Price$125.09
Change+$1.14 (+0.92%)
Volume$100
Capitalization6.97B
A vs RGEN Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. RGEN commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and RGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (A: $125.94 vs. RGEN: $123.95)
Brand notoriety: A and RGEN are both not notable
A represents the Medical Specialties, while RGEN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 79% vs. RGEN: 70%
Market capitalization -- A: $35.7B vs. RGEN: $6.97B
A [@Medical Specialties] is valued at $35.7B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $6.97B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 6 bearish.
  • RGEN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RGEN is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -0.98% price change this week, while RGEN (@Pharmaceuticals: Other) price change was +3.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.98%. For the same industry, the average monthly price growth was +3.76%, and the average quarterly price growth was +26.54%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.26%. For the same industry, the average monthly price growth was -1.79%, and the average quarterly price growth was +9.31%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.26% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($35.7B) has a higher market cap than RGEN($6.97B). RGEN has higher P/E ratio than A: RGEN (521.44) vs A (29.43). A YTD gains are higher at: -5.856 vs. RGEN (-13.888). A has higher annual earnings (EBITDA): 1.8B vs. RGEN (99.5M). A has more cash in the bank: 1.54B vs. RGEN (709M). RGEN has less debt than A: RGEN (686M) vs A (3.41B). A has higher revenues than RGEN: A (6.79B) vs RGEN (674M).
ARGENA / RGEN
Capitalization35.7B6.97B512%
EBITDA1.8B99.5M1,806%
Gain YTD-5.856-13.88842%
P/E Ratio29.43521.446%
Revenue6.79B674M1,007%
Total Cash1.54B709M217%
Total Debt3.41B686M497%
FUNDAMENTALS RATINGS
A vs RGEN: Fundamental Ratings
A
RGEN
OUTLOOK RATING
1..100
769
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
4592
PRICE GROWTH RATING
1..100
5360
P/E GROWTH RATING
1..100
452
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (53) in the Biotechnology industry is somewhat better than the same rating for RGEN (95). This means that A’s stock grew somewhat faster than RGEN’s over the last 12 months.

A's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as RGEN (100). This means that A’s stock grew similarly to RGEN’s over the last 12 months.

A's SMR Rating (45) in the Biotechnology industry is somewhat better than the same rating for RGEN (92). This means that A’s stock grew somewhat faster than RGEN’s over the last 12 months.

A's Price Growth Rating (53) in the Biotechnology industry is in the same range as RGEN (60). This means that A’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for A (45). This means that RGEN’s stock grew somewhat faster than A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
62%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 16 days ago
60%
Bearish Trend 13 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
AUDJPY97.51N/A
N/A
Australian Dollar - Japan Yen
CHFJPY186.41N/A
N/A
Switzerland Franc - Japan Yen
GBPCAD1.87N/A
N/A
United Kingdom Pound - Canadian Dollar
JPYNZD0.01N/A
N/A
Japan Yen - New Zealand Dollar
QDTE35.77-0.22
-0.63%
Roundhill Innovt-100 0DTE CovCllStratETF

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-0.31%
MTD - A
85%
Closely correlated
-0.08%
TMO - A
79%
Closely correlated
-1.10%
WAT - A
79%
Closely correlated
-1.08%
RVTY - A
78%
Closely correlated
-0.65%
DHR - A
75%
Closely correlated
-0.39%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
-1.58%
DHR - RGEN
67%
Closely correlated
-0.39%
A - RGEN
66%
Loosely correlated
-0.31%
BIO - RGEN
63%
Loosely correlated
-0.46%
MTD - RGEN
61%
Loosely correlated
-0.08%
BLFS - RGEN
59%
Loosely correlated
-2.10%
More